Evidence map›Paper›PMID 26528249›Full record

ArticleFrontiers in microbiology2015

Bacillus cereus efflux protein BC3310 - a multidrug transporter of the unknown major facilitator family, UMF-2.

Jasmin K Kroeger, Karl Hassan, Aniko Vörös, Roger Simm, Massoud Saidijam, Kim E Bettaney, Andreas Bechthold, Ian T Paulsen, Peter J F Henderson, Anne-Brit Kolstø

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Jasmin K KroegerLaboratory for Microbial Dynamics, Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo Oslo, Norway ; Institut für Pharmazeutische Biologie und Biotechnologie, Albert-Ludwigs Universität Freiburg, Germany.
Karl HassanDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney NSW, Australia.
Aniko VörösLaboratory for Microbial Dynamics, Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo Oslo, Norway.
Roger SimmLaboratory for Microbial Dynamics, Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo Oslo, Norway.
Massoud SaidijamSchool of BioMedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds Leeds, UK.
Kim E BettaneySchool of BioMedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds Leeds, UK.
Andreas BechtholdInstitut für Pharmazeutische Biologie und Biotechnologie, Albert-Ludwigs Universität Freiburg, Germany.
Ian T PaulsenDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney NSW, Australia.
Peter J F HendersonSchool of BioMedical Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds Leeds, UK.
Anne-Brit KolstøLaboratory for Microbial Dynamics, Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo Oslo, Norway.
University of Oslo · NOMacquarie University · AUUniversity of Leeds · GBHamedan University of Medical Sciences · IRUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phylogenetic classification divides the major facilitator superfamily (MFS) into 82 families, including 25 families that are comprised of transporters with no characterized functions. This study describes functional data for BC3310 from Bacillus cereus ATCC 14579, a member of the "unknown major facilitator family-2" (UMF-2). BC3310 was shown to be a multidrug efflux pump conferring resistance to ethidium bromide, SDS and silver nitrate when heterologously expressed in Escherichia coli DH5α ΔacrAB. A conserved aspartate residue (D105) in putative transmembrane helix 4 was identified, which was essential for the energy dependent ethidium bromide efflux by BC3310. Transport proteins of the MFS comprise specific sequence motifs. Sequence analysis of UMF-2 proteins revealed that they carry a variant of the MFS motif A, which may be used as a marker to distinguish easily between this family and other MFS proteins. Genes orthologous to bc3310 are highly conserved within the B. cereus group of organisms and thus belong to the core genome, suggesting an important conserved functional role in the normal physiology of these bacteria.

Indexed as

Bacillus cereusdrug resistanceefflux proteinMFSUMF-2

Identifiers

PMID26528249
PMCPMC4601019
OpenAlexW2107267742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.